IN2012DN01638A - - Google Patents

Download PDF

Info

Publication number
IN2012DN01638A
IN2012DN01638A IN1638DEN2012A IN2012DN01638A IN 2012DN01638 A IN2012DN01638 A IN 2012DN01638A IN 1638DEN2012 A IN1638DEN2012 A IN 1638DEN2012A IN 2012DN01638 A IN2012DN01638 A IN 2012DN01638A
Authority
IN
India
Prior art keywords
present
bifidobacterium longum
relates
disorders
treat
Prior art date
Application number
Inventor
Peter Mclean
Degonda Gabriela Bergonzelli
Stephen Michael Collins
Premysl Bercik
De Bercik Elena Verdu
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41508246&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2012DN01638(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of IN2012DN01638A publication Critical patent/IN2012DN01638A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/533—Longum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Physiology (AREA)
  • Animal Husbandry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention generally relates to the field of probiotic bacteria. In particular it relates to Bifidobacterium longum,such as Bifidobacterium longum ATCC BAA-999, and its use in ingestible compositions. The composition described in the present invention may be used to treat or prevent functional GI disorders.
IN1638DEN2012 2009-08-25 2010-08-24 IN2012DN01638A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09168590.9A EP2289527B1 (en) 2009-08-25 2009-08-25 Bifidobacterium longum and functional GI disorders
PCT/EP2010/062320 WO2011023689A1 (en) 2009-08-25 2010-08-24 Bifidobacterium longum and functional gi disorders

Publications (1)

Publication Number Publication Date
IN2012DN01638A true IN2012DN01638A (en) 2015-06-05

Family

ID=41508246

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1638DEN2012 IN2012DN01638A (en) 2009-08-25 2010-08-24

Country Status (17)

Country Link
US (3) US10028981B2 (en)
EP (2) EP2289527B1 (en)
JP (4) JP2013503130A (en)
CN (2) CN102573863A (en)
AU (1) AU2010288546B2 (en)
BR (1) BR112012004046B1 (en)
CA (1) CA2772163C (en)
CL (1) CL2012000487A1 (en)
DK (1) DK2289527T3 (en)
ES (1) ES2664828T3 (en)
IN (1) IN2012DN01638A (en)
MX (1) MX2012002402A (en)
RU (1) RU2012111253A (en)
SG (1) SG178499A1 (en)
TR (1) TR201807143T4 (en)
WO (1) WO2011023689A1 (en)
ZA (1) ZA201202155B (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2110028A1 (en) 2008-04-15 2009-10-21 Nestec S.A. Bifidobacterium longum and hippocampal BDNF expression
TR201807143T4 (en) 2009-08-25 2018-06-21 Nestec Sa Bifidobacterium longum and functional gastrointestinal disorders.
EP2452576A1 (en) * 2010-11-11 2012-05-16 Nestec S.A. Extruded non-replicating probiotic micro-organisms and their health benefits
EP2836224A4 (en) 2012-02-29 2015-12-16 Ethicon Endo Surgery Inc MICROBIOTA COMPOSITIONS AND ASSOCIATED METHODS
US11179427B2 (en) 2013-01-21 2021-11-23 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
JP6637885B2 (en) 2013-07-21 2020-01-29 ペンデュラム セラピューティクス， インコーポレイテッド Methods and systems for microbiome characterization, monitoring, and treatment
US20150305385A1 (en) * 2014-04-25 2015-10-29 Mead Johnson Nutrition Company Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics
CA2964480A1 (en) 2014-10-31 2016-05-06 Whole Biome Inc. Methods and compositions relating to microbial treatment and diagnosis of disorders
WO2016183535A1 (en) 2015-05-14 2016-11-17 University Of Puerto Rico Methods for restoring microbiota of newborns
MX382895B (en) 2015-06-11 2025-03-13 Soc Des Produits Nestle S A Star DIETARY SUPPLEMENT.
EP3344268A1 (en) * 2015-08-31 2018-07-11 Nestec S.A. Methods and compositions using bifidobacterium longum to modulate emotional reactivity and treat or prevent sub-clinical mood disturbances
WO2017037105A1 (en) * 2015-08-31 2017-03-09 Nestec S.A. Methods and compositions using bifidobacterium longum to optimize breastfeeding
JP2018525390A (en) * 2015-08-31 2018-09-06 ネステク ソシエテ アノニム Methods and compositions using Bifidobacterium longum for treating or preventing depressive symptoms
PL3368046T3 (en) * 2015-10-28 2022-11-28 Glycom A/S Synthetic composition and method for modulating brain function and behaviour
US10780103B2 (en) 2015-10-28 2020-09-22 Glycom A/S Synthetic composition and method for modulating emotion and mood disorders
WO2017117142A1 (en) 2015-12-28 2017-07-06 New York University Device and method of restoring microbiota of newborns
JP6353478B2 (en) * 2016-03-28 2018-07-04 日清食品ホールディングス株式会社 Bifidobacteria capable of promoting serotonin secretion
CN107050062A (en) * 2016-11-08 2017-08-18 江西益盟科技有限公司 Treat lactic bacteria composition of constipation and preparation method thereof
CN106579414A (en) * 2016-12-26 2017-04-26 北京康比特体育科技股份有限公司 Composition for relieving motility diarrhea
JP7055814B2 (en) * 2017-02-28 2022-04-18 プリシジョンバイオティクス・グループ・リミテッド Bifidobacterium longum that can advantageously regulate the immune response to respiratory viral infections
EP3589726A1 (en) 2017-02-28 2020-01-08 Alimentary Health Limited Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection
EP3618843A1 (en) * 2017-05-05 2020-03-11 Société des Produits Nestlé S.A. Treatment of infant colic
JP2020532515A (en) 2017-08-30 2020-11-12 ペンデュラム セラピューティクス， インコーポレイテッド Methods and compositions for the treatment of microbiome-related disorders
JP7285096B2 (en) 2018-03-28 2023-06-01 森永乳業株式会社 COMPOSITION FOR STRESS RELIEF AND PHARMACEUTICAL COMPOSITIONS AND FOOD AND FOOD COMPOSITIONS USING THE COMPOSITION FOR STRESS RELIEF
EP3823651A4 (en) 2018-07-19 2022-04-27 Pendulum Therapeutics, Inc. METHODS AND COMPOSITIONS FOR MICROBIAL GRAFT
CN114402062B (en) * 2019-07-01 2025-02-25 雀巢产品有限公司 Serine protease inhibitors
BR112021024311A2 (en) * 2019-07-01 2022-01-11 Nestle Sa serpin production
JP2021014421A (en) * 2019-07-11 2021-02-12 日清ファルマ株式会社 Qol improving agent
JP2021014422A (en) * 2019-07-11 2021-02-12 日清ファルマ株式会社 Fecal state improving agent
CN111187734A (en) * 2019-12-25 2020-05-22 生合生物科技（扬州）有限公司 Bifidobacterium longum BL986, freeze-dried powder prepared from bifidobacterium longum BL986 and application of freeze-dried powder
WO2021180973A1 (en) 2020-03-13 2021-09-16 Precisionbiotics Group Limited Bifidobacterium longum
US12496324B2 (en) 2020-05-20 2025-12-16 Societe Des Produits Nestle S.A. Insoluble fibre fermentability and short chain fatty acid production by Bifidobacterium longum
WO2026078486A1 (en) * 2024-10-11 2026-04-16 Kolinpharma S.P.A. Composition for the prevention and treatment of intestinal diseases characterised by pain and inflammation

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH637297A5 (en) 1978-12-05 1983-07-29 Nestle Sa MICROBALL COMPRISING A MICROORGANISM AND ITS MANUFACTURING METHOD.
ID29150A (en) 1999-01-15 2001-08-02 Entpr Ireland Cs USE OF LACTOBACILLUS SALIVARIUS
DE10008279A1 (en) * 2000-02-23 2001-08-30 Meggle Gmbh Synergistic medicinal or health-promoting food additive composition, comprising lactose, inulin and/or oligofructose, calcium salt and Bifidus bacteria, having e.g. immunostimulant and digestion improving action
US6592863B2 (en) * 2000-08-22 2003-07-15 Nestec S.A. Nutritional composition
US20030092163A1 (en) * 2001-07-26 2003-05-15 Collins John Kevin Probiotic bifidobacterium strains
WO2003020048A1 (en) * 2001-08-31 2003-03-13 Nutricopia, Inc. Nutritional frozen dessert and methods of menufacture
EP1384483A1 (en) * 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
AU2003303894A1 (en) * 2003-01-30 2004-08-30 The Regents Of The University Of California Inactivated probiotic bacteria and methods of use thereof
JP2004262773A (en) 2003-02-17 2004-09-24 Ryoshoku Kenkyukai Bifidobacterium preparation for improving immune function
US20040265279A1 (en) * 2003-05-08 2004-12-30 Timothy Dinan Probiotics in the treatment of atypical depression and other disorders characterized by hypothalamic pitiuitary-adrenal axis over-activity
ATE433674T1 (en) * 2003-06-23 2009-07-15 Nestec Sa INFANT NUTRITIONAL PREPARATION OR FOLLOW-ON MILK
US20050100559A1 (en) * 2003-11-07 2005-05-12 The Procter & Gamble Company Stabilized compositions comprising a probiotic
US20060093592A1 (en) * 2004-10-04 2006-05-04 Nutracea Synbiotics
US8134942B2 (en) * 2005-08-24 2012-03-13 Avaak, Inc. Communication protocol for low-power network applications and a network of sensors using the same
DE602006017423D1 (en) * 2005-11-14 2010-11-18 Unilever Nv EDIBLE PRODUCT CONTAINING GINSENG POLYSACCHARIDES AND HEALTHY BACTERIA
JP2007169200A (en) * 2005-12-21 2007-07-05 Morinaga Milk Ind Co Ltd Medicine and food/drink for prophylaxis of influenza infection
ES2381211T3 (en) * 2006-02-15 2012-05-24 Nestec S.A. Use of Bifidobacterium longum to prevent and treat inflammations
RU2448720C2 (en) 2006-03-07 2012-04-27 Нестек С.А. Synbiotic mixture
EP1961308A1 (en) * 2007-02-21 2008-08-27 Nestec S.A. Nutritionally balanced frozen dessert
EP1974735A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Reduction of risk of diarrhoea
EP1974743A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota
EP2227239A2 (en) * 2007-12-06 2010-09-15 Arla Foods Amba Probiotic bacteria and regulation of fat storage
CA2709579A1 (en) * 2007-12-17 2009-06-25 University Of Florida Research Foundation, Inc. Materials and methods for treatment of pathological ocular vascular proliferation
EP2110028A1 (en) * 2008-04-15 2009-10-21 Nestec S.A. Bifidobacterium longum and hippocampal BDNF expression
WO2010008272A1 (en) * 2008-07-15 2010-01-21 N.V. Nutricia Treatment of gut motility disorders
TR201807143T4 (en) 2009-08-25 2018-06-21 Nestec Sa Bifidobacterium longum and functional gastrointestinal disorders.
DK3745870T3 (en) * 2018-01-29 2023-02-20 Prec Group Limited A COMBINATION PRODUCT FOR THE PROPHYLAXIS AND TREATMENT OF IRRITABLE BOWEL SYNDROME

Also Published As

Publication number Publication date
ZA201202155B (en) 2014-09-25
US11452745B2 (en) 2022-09-27
TR201807143T4 (en) 2018-06-21
JP2016074682A (en) 2016-05-12
CL2012000487A1 (en) 2012-08-31
JP7096652B2 (en) 2022-07-06
US11957720B2 (en) 2024-04-16
WO2011023689A1 (en) 2011-03-03
JP2013503130A (en) 2013-01-31
JP7096652B6 (en) 2022-08-01
CA2772163C (en) 2017-11-07
MX2012002402A (en) 2012-04-02
US20190134104A1 (en) 2019-05-09
AU2010288546B2 (en) 2015-08-20
JP2020183385A (en) 2020-11-12
CN102573863A (en) 2012-07-11
US10028981B2 (en) 2018-07-24
BR112012004046B1 (en) 2021-02-17
AU2010288546A1 (en) 2012-03-22
SG178499A1 (en) 2012-04-27
EP2470188A1 (en) 2012-07-04
RU2012111253A (en) 2013-10-10
JP2018048112A (en) 2018-03-29
CN106072658A (en) 2016-11-09
DK2289527T3 (en) 2018-04-23
CA2772163A1 (en) 2011-03-03
ES2664828T3 (en) 2018-04-23
BR112012004046A2 (en) 2017-05-30
US20120230956A1 (en) 2012-09-13
EP2289527B1 (en) 2018-02-21
EP2289527A1 (en) 2011-03-02
US20220280576A1 (en) 2022-09-08

Similar Documents

Publication Publication Date Title
IN2012DN01638A (en)
GB2480042A (en) Prebiotic formulations and methods of use
UA109876C2 (en) Composition containing bifidobacterium longum cncm i-2618 for use in treatment or prevention of disorders related to immune system
GB2511993A (en) Prebiotic formulations and methods of use
UA107711C2 (en) Use of lactobacilli inhibiting gas producing coliform bacteria isolated from infants affected by colic
PH12013500931A1 (en) Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
UA100551C2 (en) Synbiotic mixture
IN2012DN02463A (en)
HRP20160598T1 (en) BACTERIAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DEGENERATIVE DISEASE
UA108198C2 (en) Substituted 2-acetamido-5-aryl-l, 2,4-triazolones and their use
WO2012112777A3 (en) Biosynthesis of human milk oligosaccharides in engineered bacteria
NZ709392A (en) Synergistic bacterial compositions and methods of production and use thereof
ATE551063T1 (en) USE OF BIFIDOBACTERIUM LONGUM FOR PROPHYLAXIS AND TREATMENT OF INFLAMMATION
MX2010008137A (en) Non-pathogenic and/or attenuated bacteria capable of inducing apoptosis in macrophages, process of manufacturing and uses thereof.
PL2513023T3 (en) Compositions and uses of cis-1,1,1,4,4,4-hexafluoro-2-butene
UA109123C2 (en) PROBIOTIC COMPOSITION FOR THE APPLICATION IN THE TREATMENT OF INTESTINAL INFLAMMATION
WO2010008491A3 (en) Lactose compositions with decreased lactose content
MY158310A (en) Prevention and treatment of allergic diarrhoea
EA201291441A1 (en) PROBIOTIC STRAINS FOR APPLICATION IN IMPROVING THE CONDITION OF THE INTESTINAL NERVOUS SYSTEM
PL2173196T3 (en) Use of probiotics and fibers for diarrhoea
GEP201606589B (en) Novel bacterium and extracts of said bacterium and the use of same in dermatology
MX2011005527A (en) Use of lactic acid bacteria to treat or prevent eczema.
PH12013500811A1 (en) Extruded non-replicating probiotic micro-organisms and their health benefits
MX342947B (en) Treatment of type 2 diabetes.
EA201291440A1 (en) PROBIOTIC STRAINS FOR APPLICATION TO IMPROVE TRANSEPSIAL RESISTANCE